Glutaminyl cyclase as a diagnostic / prognostic indicator for neurodegenerative diseases

Details for Australian Patent Application No. 2009275869 (hide)

Owner Probiodrug AG

Inventors Demuth, Hans-Ulrich; Schilling, Stephan; Kleinschmidt, Martin; Rahfeld, Jens-Ulrich; Kehlen, Astrid; Bornack, Monique

Agent Watermark

Pub. Number AU-A-2009275869

PCT Pub. Number WO2010/012828

Priority 61/085,154 31.07.08 US

Filing date 31 July 2009

Wipo publication date 4 February 2010

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/012828 Priority application(s): WO2010/012828

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009275875-Method for the in vitro diagnosis of stroke

2009275867-Cover and related products, and production thereof